Definitive Healthcare Corp
$ 1.39
0.72%
24 Feb - close price
- Market Cap 143,639,000 USD
- Current Price $ 1.39
- High / Low $ 1.44 / 1.36
- Stock P/E N/A
- Book Value 2.77
- EPS -1.72
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.49 %
- 52 Week High 5.22
- 52 Week Low 1.36
About
Definitive Healthcare Corp (DH) is a prominent data and analytics provider tailored for the healthcare sector, offering in-depth insights that empower clients such as pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and emphasizing real-time analytics, DH enhances operational efficiency and informs strategic decision-making. The company is strategically positioned to benefit from the increasing demand for healthcare analytics, thus facilitating improved patient outcomes and optimizing operational performance in an ever-evolving industry landscape. As a vital collaborator for stakeholders navigating the complexities of healthcare, Definitive Healthcare underscores its commitment to driving innovation and competitive advantage within the sector.
Analyst Target Price
$3.91
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-19 | 2025-11-06 | 2025-08-04 | 2025-05-05 | 2025-02-26 | 2024-11-07 | 2024-08-05 | 2024-05-07 | 2024-02-28 | 2023-11-02 | 2023-08-14 | 2023-05-04 |
| Reported EPS | 0 | 0.07 | 0.07 | 0.05 | 0.08 | 0.1 | 0.09 | 0.08 | 0.07 | 0.09 | 0.08 | 0.06 |
| Estimated EPS | 0.061 | 0.06 | 0.05 | 0.0248 | 0.0718 | 0.08 | 0.09 | 0.08 | 0.08 | 0.06 | 0.06 | 0.04 |
| Surprise | -0.061 | 0.01 | 0.02 | 0.0252 | 0.0082 | 0.02 | 0 | 0 | -0.01 | 0.03 | 0.02 | 0.02 |
| Surprise Percentage | -100% | 16.6667% | 40% | 101.6129% | 11.4206% | 25% | 0% | 0% | -12.5% | 50% | 33.3333% | 50% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DH
2026-02-11 01:58:07
Definitive Healthcare Corp. (NASDAQ:DH) has seen its shares drop significantly, with a 26% decline in the last month and a 65% drop over the past year. Its low price-to-sales (P/S) ratio of 0.8x, compared to an industry average of 2.1x, reflects declining revenues and a negative growth outlook. Analysts forecast a 3.0% revenue decrease for the company while the industry is expected to grow by 12%, justifying the current low valuation but signaling potential difficulties for share price recovery.
2026-02-02 06:58:43
Definitive Healthcare Corp. (NASDAQ:DH) has received a consensus "Hold" rating from eight brokerages, with an average 12-month price target of $3.94. The company recently beat its earnings and revenue estimates but still posted a negative net margin of 77.88%. Institutional investors hold approximately 98.67% of the company's stock, which currently trades around $2.32.
2026-01-29 21:19:00
Definitive Healthcare Corp. (Nasdaq: DH) plans to announce its financial results for the fourth quarter and full year ended December 31, 2025, on February 26, 2026, after market close. The company will host a conference call and webcast at 5:00 PM ET to discuss the results, with replay options available until March 26, 2026. This announcement highlights their commitment to transparency and investor engagement, detailing recent hedge fund activity and analyst ratings, including a "Buy" rating from Stifel.
2026-01-29 21:19:00
Definitive Healthcare Corp. (Nasdaq: DH) plans to release its financial results for the fourth quarter and full fiscal year ending December 31, 2025, on February 26, 2026, after the market closes. Following the announcement, the company will host a conference call and webcast at 5:00 PM ET to discuss the results and engage with investors. The article also provides details on Definitive Healthcare's recent financial performance, hedge fund activity, analyst ratings, and price targets.
2026-01-20 02:57:36
Analysts have issued neutral ratings for AMN Healthcare Services (AMN) and Definitive Healthcare Corp (DH), indicating neither bullish nor bearish sentiment. Needham analyst Ryan MacDonald maintained a Hold rating on Definitive Healthcare Corp, whose shares closed at $2.43. The consensus price target for Definitive Healthcare Corp is $3.71.
2026-01-18 16:57:13
Definitive Healthcare Corp. (NASDAQ:DH) experienced a 23.2% drop in short interest in December, reaching 2,248,253 shares, representing 1.9% of its shares sold short and a short-interest ratio of 2.9 days. Analysts generally have a "Hold" rating with an average target price of $3.94, despite recent downgrades and lower price targets from several firms. The company's stock currently trades at $2.39, with a market capitalization of approximately $338 million, after reporting mixed financial results including beating quarterly EPS estimates but having a deeply negative net margin.
